Baxter International Shareholders Urged to Join Class Action for Claims of Defective Products

Shareholders of Baxter International, Inc. Invited to Join Class Action



Investors who experienced losses with Baxter International, Inc. (NYSE: BAX) may have a chance to recover those funds through a class action lawsuit. The Gross Law Firm, a well-established class action law firm, has announced their intent to represent affected shareholders who purchased shares during the class period from February 23, 2022, to October 29, 2025.

Details of the Class Action


The class action centers around numerous allegations indicating that Baxter International's recently launched product, the Novum LVP, suffered systemic defects that endangered patient safety. Reports suggest that the product caused serious malfunctions, such as underinfusion, overinfusion, and complete non-delivery of fluids. Consequently, patients may have been exposed to the heightened risk of severe injury or even death. Allegations further state that Baxter had prior knowledge of these multifaceted device malfunctions, including serious injuries and fatalities linked to the product’s defects.

In addition, the lawsuit claims that Baxter's attempts to remedy the issues through customer notifications were insufficient. Design flaws persisted, leading to continued harm. This culminated in a situation where customers were potentially instructed to remove Novum LVPs from service, and there was speculation that Baxter might cease all new sales of these pumps altogether. As a result, Baxter's assurances regarding the product's safety and efficacy were deemed materially misleading.

Importance of Acting Promptly


Shareholders are urged not to delay in registering for the class action. The deadline to apply as a lead plaintiff is December 15, 2025. Those interested have the opportunity to enroll in a portfolio monitoring service to track updates on the case. It is essential to note that there is no requirement to become a lead plaintiff in order to partake in potential recovery from the case.

Why Choose The Gross Law Firm?


The Gross Law Firm is recognized nationally for its commitment to protecting investors and holding companies accountable for unethical practices. The firm’s mission focuses on ensuring businesses adhere to responsible practices, thereby mitigating deceit, fraud, and illegal business activities that impact shareholders adversely. If you've suffered losses as a result of Baxter's allegedly misleading statements, now is the time to take action and seek justice.

Contact Information


Affected shareholders should reach out to The Gross Law Firm for further guidance. You can contact them via their official website to register your information and start the process. The Gross Law Firm is located at 15 West 38th Street, 12th floor, New York, NY, 10018, and can be reached via email or phone at (646) 453-8903.

In conclusion, this class action represents a crucial avenue for investors who have incurred losses due to Baxter International, Inc.'s alleged failure to uphold product safety standards. Don’t miss the opportunity to protect your rights as a shareholder. Ensure you act before the upcoming deadline to join the litigation efforts against Baxter.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.